18
Giuseppe Tisone CURRICULUM VITAE CV 2016 Page 1 of 14 1. Name First name: Giuseppe Last name: Tisone 2. Present Position with Work Address Position: Head of Unità Operativa Complessa Chirurgia dei Trapianti Street address or postal address: Viale Oxford, 81 Name of institution or organization: Unità Operativa Complessa Chirurgia dei Trapianti Fondazione PTV Policlinico Tor Vergata City & postal/zip code: Rome / 00133 Start date (at least year): 2004 Country: Italy 3. Main University Degree(s) Name of university/institute: Università degli Studi di Roma “La Sapienza” Degree awarded: Degree in Medicine and Surgery City & country: Rome, Italy Year of graduation: 1980 Name of university/institute: Università degli Studi di Roma “La Sapienza” Degree awarded: General Surgery City & country: Rome, Italy Year of graduation: 1985 Name of university/institute: Università degli Studi di Roma “La Sapienza” Degree awarded: Vascular Surgery City & country: Roma/Italy Year of graduation: 1990 4. Professional Training Name of university/institute: Mount Sinai Medical Center – Transplant Department City & country: New York / USA Qualification: Fellow Dates of attendance: 1981 Name of university/institute: Moffit Hospital - Transplant Department City & country: San Francisco / USA Qualification: Fellow Dates of attendance: 1981 Name of university/institute: Queen Elizabeth Hospital – Surgery Department University of Birmingham (UK) City & country: Birmingham / United Kingdom Qualification: Researcher in surgery area on kidney and liver transplant. Dates of attendance: 1984, 1987, 1990, 1991 and 1995 Name of university/institute: Addensbrook Hospital – Transplant unit City & country: Cambridge / United Kingdom Qualification: Researcher Dates of attendance: February – March 1987 5. Registration/Medical License number (where applicable) Number: NA

Giuseppe Tisone CURRICULUM VITAEmedschool.uniroma2.it/wp-content/uploads/2017/09/CV-inglese-Prof... · 2004 Country: Italy 3. Main University Degree(s) ... Ponticelli C, Carmellini

  • Upload
    vudien

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 1 of 14

1. Name First name: Giuseppe

Last name: Tisone

2. Present Position with Work Address Position: Head of Unità Operativa Complessa Chirurgia dei Trapianti

Street address or postal address: Viale Oxford, 81

Name of institution or organization: Unità Operativa Complessa Chirurgia dei Trapianti Fondazione PTV Policlinico Tor Vergata

City & postal/zip code: Rome / 00133

Start date (at least year): 2004

Country: Italy

3. Main University Degree(s) Name of university/institute: Università degli Studi di Roma “La Sapienza”

Degree awarded: Degree in Medicine and Surgery

City & country: Rome, Italy

Year of graduation: 1980

Name of university/institute: Università degli Studi di Roma “La Sapienza”

Degree awarded: General Surgery

City & country: Rome, Italy

Year of graduation: 1985

Name of university/institute: Università degli Studi di Roma “La Sapienza”

Degree awarded: Vascular Surgery

City & country: Roma/Italy

Year of graduation: 1990

4. Professional Training Name of university/institute: Mount Sinai Medical Center – Transplant Department

City & country: New York / USA

Qualification: Fellow

Dates of attendance: 1981

Name of university/institute: Moffit Hospital - Transplant Department

City & country: San Francisco / USA

Qualification: Fellow

Dates of attendance: 1981

Name of university/institute: Queen Elizabeth Hospital – Surgery Department University of Birmingham (UK)

City & country: Birmingham / United Kingdom

Qualification: Researcher in surgery area on kidney and liver transplant.

Dates of attendance: 1984, 1987, 1990, 1991 and 1995

Name of university/institute: Addensbrook Hospital – Transplant unit

City & country: Cambridge / United Kingdom

Qualification: Researcher

Dates of attendance: February – March 1987

5. Registration/Medical License number (where applicable) Number:

NA

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 2 of 14

6. Previous Appointments Position: Researcher in Clinical Surgery

Dates: 1984 - 2000

Institution/organization: Università degli Studi di Roma “Tor Vergata

City & country: Rome, Italy

Position: Associate Professor

Dates: 2000-2004

Institution/organization: Università degli Studi di Roma “Tor Vergata”

City & country: Rome, Italy

7. Research activities

• Immunosuppression after liver transplantation, primarily focused on its weaning • Tolerance after transplantation • Techniques of organ conservation • Transplantation • Biliary acids in liver transplant • HCV recurrence after Liver transplantation

8. Operating cases Performed as First surgeon about 3000 surgical operations (700 liver transplants, many kidney transplants, 700 liver resections, 100 pancreatic resections...) and many laparoscopic operations. 9. University activities Professor of Hepatobiliary Surgery in the Medical School, “Tor Vergata” University of Rome. Professor of General Surgery and Orthopaedics and Trauma Surgical Post-graduate Schools, “Tor Vergata” University of Rome. In the last years Professor Lecturer in many courses about Transplantation.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 3 of 14

List of publications

1. Tariciotti L, D'Ugo S, Manzia TM, Tognoni V, Sica G, Gentileschi P, Tisone G. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report. Int J Surg Case Rep. 2016 Sep 21;28:38-41.

2. Filingeri V, Francioso S, Sforza D, Santopaolo F, Oddi FM, Tisone G. A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3609-17.

3. Manzia TM, Fazzolari L, Manuelli M, Pellicciaro M, Baiocchi L, Tisone G. Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report. Ann Med Surg (Lond). 2016 Aug 19;11:5-8

4. De Simone P, Fagiuoli S, Cescon M, De Carlis L, Tisone G, Volpes R, Cillo U; Consensus Panel. Use of Everolimus in Liver Transplantation: Recommendations From a Working Group. Transplantation. 2016 Aug 5.

5. Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CT, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw AS, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016 Jun 7.

6. Lenci I, Baiocchi L, Tariciotti L, Di Paolo D, Milana M, Santopaolo F, Manzia TM, Toti L, Svicher V, Tisone G, Perno CF, Angelico M. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression. Liver Transpl. 2016 Sep;22(9):1205-13.

7. Orlacchio A, Chegai F, Fabiano S, Merolla S, Funel V, Di Giuliano F, Manuelli M, Tisone G, Francioso S, Angelico M, Palmieri G, Simonetti G. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers. Radiol Med. 2016 Jul;121(7):588-96.

8. De Simone P, Romagnoli R, Tandoi F, Carrai P, Ercolani G, Peri E, Zamboni F, Mameli L, Di Benedetto F, Cillo U, De Carlis L, Lauterio A, Lupo L, Tisone G, Prieto M, Loinaz C, Mas A, Suddle A, Mutimer D, Roche B, Wartenberg-Demand A, Niemann G, Böhm H, Samuel D. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study. Transplantation. 2016 Jul;100(7):1507-12.

9. Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, Napoli N, Boggi U. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. Ann Surg Oncol. 2016 Jun;23(6):2028-37.

10. Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group.Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. Am J Kidney Dis. 2016 Apr;67(4):648-59.

11. Manzia TM, Angelico R, Toti L, Belardi C, Cillis A, Quaranta C, Tariciotti L, Katari R, Mogul A, Sforza D, Orlando G, Tisone G. The efficacy and safety of mammalian target of rapamycin inhibitors ab

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 4 of 14

initio after liver transplantation without corticosteroids or induction therapy. Dig Liver Dis. 2016 Mar;48(3):315-20.

12. Di Maio VC, Cento V, Di Paolo D, Aragri M, De Leonardis F, Tontodonati M, Micheli V, Bellocchi MC, Antonucci FP, Bertoli A, Lenci I, Milana M, Gianserra L, Melis M, Di Biagio A, Sarrecchia C, Sarmati L, Landonio S, Francioso S, Lambiase L, Nicolini LA, Marenco S, Nosotti L, Giannelli V, Siciliano M, Romagnoli D, Pellicelli A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Taliani G, Mastroianni C, Vespasiani-Gentilucci U, Romano M, Morisco F, Gasbarrini A, Vullo V, Bruno S, Baiguera C, Pasquazzi C, Tisone G, Picciotto A, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F; HCV Italian Resistance Network Study Group. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. J Antimicrob Chemother. 2016 Mar;71(3):739-50. doi: 10.1093/jac/dkv403. Epub 2015 Dec 17.

13. Orlacchio A, Chegai F, Merolla S, Francioso S, Giudice CD, Angelico M, Tisone G, Simonetti G. Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization. World J Hepatol. 2015 Jun 28;7(12):1694-700.

14. Filingeri V, Sforza D, Tisone G. Complications and risk factors of a large series of percutaneous liver biopsies in patients with liver transplantation or liver disease. Eur Rev Med Pharmacol Sci. 2015 May;19(9):1621-9

15. Piselli P, Burra P, Lauro A, Baccarani U, Ettorre GM, Vizzini GB, Rendina M, Rossi M, Tisone G, Zamboni F, Bortoluzzi I, Pinna AD, Risaliti A, Galatioto L, Vennarecci G, Di Leo A, Nudo F, Sforza D, Fantola G, Cimaglia C, Verdirosi D, Virdone S, Serraino D; Italian Transplant and Cancer Cohort Study. Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997-2010. Transpl Int. 2015 Jul;28(7):841-8. doi: 10.1111/tri.12555. Epub 2015 Mar 31.

16. TruneČka P, Klempnauer J, Bechstein WO, Pirenne J, Friman S, Zhao A, Isoniemi H, Rostaing L, Settmacher U, Mönch C, Brown M, Undre N, Tisone G; DIAMOND† study group. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. Am J Transplant. 2015 Jul;15(7):1843-54. doi: 10.1111/ajt.13182. Epub 2015 Feb 23.

17. Adam R, Karam V, Delvart V, Trunečka P, Samuel D, Bechstein WO, Němec P, Tisone G, Klempnauer J, Rossi M, Rummo OO, Dokmak S, Krawczyk M, Pratschke J, Kollmar O, Boudjema K, Colledan M, Ericzon BG, Mantion G, Baccarani U, Neuhaus P, Paul A, Bachellier P, Zamboni F, Hanvesakul R, Muiesan P; European Liver Intestine Transplant Association (ELITA). Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant. 2015 May;15(5):1267-82. doi: 10.1111/ajt.13171. Epub 2015 Feb 19.

18. Manzia TM, Tariciotti L, Angelico R, Toti L, Anselmo A, Tisone G.Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis. Int J Surg Case Rep. 2015;6C:222-5. doi: 10.1016/j.ijscr.2014.10.037.

19. Ponticelli C, Carmellini M, Tisone G, Sandrini S, Segoloni G, Rigotti P, Colussi G, Stefoni S. A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? Transplant Proc. 2014 Dec;46(10):3375-82.

20. Orlando G, Manzia TM, Sorge R, Iaria G, Angelico R, Sforza D, Toti L, Peloso A, Patel T, Katari R, Zambon JP, Maida A, Salerno MP, Clemente K, Di Cocco P, De Luca L, Tariciotti L, Famulari A,

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 5 of 14

Citterio F, Tisone G, Pisani F, Romagnoli J. One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Surgery. 2015 Jan;157(1):104-10. doi: 10.1016/j.surg.2014.06.007. Epub 2014 Oct 8.

21. Ferlosio A, Manzia TM, Anemona L, Tisone G, Orlandi A. Myopericytoma of the liver hilus: a case report. Turk Patoloji Derg. 2014;30(3):215

22. Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. Am J Transplant. 2014 Dec;14(12):2796-806. doi: 10.1111/ajt.12955.

23. Manzia TM, Angelico R, Ciano P, Mugweru J, Owusu K, Sforza D, Toti L, Tisone G. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients. World J Gastroenterol. 2014 Sep 14;20(34):12217-25.

24. Orlacchio A, Chegai F, Del Giudice C, Anselmo A, Iaria G, Palmieri G, Di Caprera E, Tosti D, Costanzo E, Tisone G, Simonetti G. Kidney transplant: usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis. Ultrasound Med Biol. 2014 Nov;40(11):2564-72.

25. Salso A, Tisone G, Tariciotti L, Lenci I, Manzia TM, Baiocchi L. Relationship between GH/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation. Biomed Res Int. 2014;2014:240873. doi: 10.1155/2014/240873. Epub 2014 Apr 1.

26. L Ponziani FR, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, Burra P, Miglioresi L, Merli M, Di Paolo D, Fagiuoli S, Gasbarrini A, Pompili M; AISF RECOLT-C Group, Belli L, Gerunda GE, Marino M, Montalti R, Di Benedetto F, De Ruvo N, Rigamonti C, Colombo M, Rossi G, Di Leo A, Lupo L, Memeo V, Bringiotti R, Zappimbulso M, Bitetto D, Vero V, Colpani M, Fornasiere E, Pinna AD, Morelli MC, Bertuzzo V, De Martin E, Senzolo M, Ettorre GM, Visco-Comandini U, Antonucci G, Angelico M, Tisone G, Giannelli V, Giusto M. ong-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. Dig Liver Dis. 2014 May;46(5):440-5. doi: 10.1016/j.dld.2014.01.157. Epub 2014 Mar 11.

27. Angelico M, Nardi A, Romagnoli R, Marianelli T, Corradini SG, Tandoi F, Gavrila C, Salizzoni M, Pinna AD, Cillo U, Gridelli B, De Carlis LG, Colledan M, Gerunda GE, Costa AN, Strazzabosco M; Liver Match Study Investigators. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. Dig Liver Dis. 2014 Apr;46(4):340-7.

28. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P, Manzia TM, Toti L, Tisone G. Deep vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: a case report. Transplant Proc. 2013 Sep;45(7):2782-4.

29. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, Sforza D, Miglioresi L, Fantola G, Cimaglia C, Vennarecci G, Vizzini GB, Di Leo A, Rossi M, Tisone G, Zamboni F, Santoro R, Agresta A, Puro V, Serraino D. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc. 2013 Sep;45(7):2729-32

30. Framarino-dei-Malatesta M, Derme M, Manzia TM, Iaria G, De Luca L, Fazzolari L, Napoli A, Berloco P, Patel T, Orlando G, Tisone G. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Expert Rev Clin Immunol. 2013 Aug;9(8):781-9.

31. Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, Goffette P, Vogel W, Pitton MB, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group. Alpha-fetoprotein and modified

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 6 of 14

response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl. 2013 Oct;19(10):1108-18.

32. Manzia TM, Sforza D, Biancone L, Tisone G. Liver abscess caused by foreign body ingestion. Dig Liver Dis. 2013 Aug;45(8):699

33. Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Prospective multi-center clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology. 2013 Mar 26.

34. Schlitt HJ, Jonas S, Ganten TM, Grannas G, Moench C, Rauchfuss F, Obed A, Tisone G, Pinna AD, Gerunda GE, Beckebaum S. Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). Clin Transplant. 2013 Feb 13.

35. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. Transpl Int. 2013 Mar;26(3):259-66.

36. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P, Manzia TM, Toti L, Tisone G. Deep

vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: a case report. Transplant Proc. 2013 Sep;45(7):2782-4. doi: 10.1016/j.transproceed.2013.07.004.

37. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, Sforza D, Miglioresi L, Fantola G, Cimaglia C,

Vennarecci G, Vizzini GB, Di Leo A, Rossi M, Tisone G, Zamboni F, Santoro R, Agresta A, Puro V, Serraino D. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc. 2013 Sep;45(7):2729-32. doi: 10.1016/j.transproceed.2013.07.050.

38. Framarino-dei-Malatesta M, Derme M, Manzia TM, Iaria G, De Luca L, Fazzolari L, Napoli A,

Berloco P, Patel T, Orlando G, Tisone G. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Expert Rev Clin Immunol. 2013 Aug;9(8):781-9. doi: 10.1586/1744666X.2013.824243.

39. Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, Goffette P, Vogel W, Pitton MB, Lerut J;

European Hepatocellular Cancer Liver Transplant Study Group. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl. 2013 Oct;19(10):1108-18. doi: 10.1002/lt.23706.

40. Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M,

López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology. 2013 Mar 26. doi: 10.1002/hep.26426. [Epub ahead of print]

41. Manzia TM, Sforza D, Biancone L, Tisone G. Liver abscess caused by foreign body ingestion. Dig

Liver Dis. 2013 Aug;45(8):699. doi: 10.1016/j.dld.2013.01.019. Epub 2013 Mar 6. No abstract available.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 7 of 14

42. Noce A, Iaria G, Durante O, Sforza D, Canale MP, Di Villahermosa SM, Castagnola V, Tisone G, Di Daniele N. Bilateral native kidney neoplasia detected by ultrasound in functionning renal allograft recipient. Arch Ital Urol Androl. 2012 Dec;84(4):253-5.

43. Schlitt HJ, Jonas S, Ganten TM, Grannas G, Moench C, Rauchfuss F, Obed A, Tisone G, Pinna AD,

Gerunda GE, Beckebaum S. Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). Clin Transplant. 2013 May-Jun;27(3):368-78. doi: 10.1111/ctr.12097. Epub 2013 Feb 13.

44. Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G.

The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int. 2013 Mar;26(3):259-66. doi: 10.1111/tri.12023. Epub 2012 Dec 20.

45. Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW,

Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28.

46. Manzia TM, Angelico R, Toti L, Lai Q, Ciano P, Angelico M, Tisone G. Hepatitis C virus recurrence

and immunosuppression-free state after liver transplantation. Expert Rev Clin Immunol. 2012 Sep;8(7):635-44. doi: 10.1586/eci.12.66. Review.

47. Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G,

Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10.

48. Manzia TM, Sforza D, Angelico R, Bellini MI, Ciano P, Manuelli M, Toti L, Tisone G. Everolimus and

enteric-coated mycophenolate sodium ab initio after liver transplantation: midterm results. Transplant Proc. 2012 Sep;44(7):1942-5. doi: 10.1016/j.transproceed.2012.06.028.

49. Carbone M, Campagnolo L, Angelico M, Tisone G, Almerighi C, Telesca C, Lenci I, Moscatelli I,

Massoud R, Baiocchi L. Leptin attenuates ischemia-reperfusion injury in the rat liver. Transpl Int. 2012 Dec;25(12):1282-8. doi: 10.1111/j.1432-2277.2012.01555.x. Epub 2012 Sep 13.

50. Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, Tisone G, Agnes S, Chok KS, Sharr W,

Rossi M, Manzia TM, Lo CM. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol. 2012 Nov;57(5):974-9. doi: 10.1016/j.jhep.2012.06.033. Epub 2012 Jul 6.

51. Smedile G, Bellini MI, Iaria G, Castrucci T, De Luca L, Leporelli P, Booth C, Orlando G, Tisone G.

Emergency endovascular repair in a patient with abdominal aortic aneurysm with pelvic transplant kidneys: case report. Exp Clin Transplant. 2012 Dec;10(6):601-4. doi: 10.6002/ect.2012.0017. Epub 2012 Jul 4.

52. Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in

immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012 Oct;18(10):1154-70. doi: 10.1002/lt.23481. Review.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 8 of 14

53. Giannelli V, Giusto M, Farcomeni A, Ponziani FR, Pompili M, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, De Martin E, Miglioresi L, Di Paolo D, Fagiuoli S, Merli M; AISF RECOLT-C group study. Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. Transpl Int. 2012 Apr;25(4):448-54. doi: 10.1111/j.1432-2277.2012.01440.x. Epub 2012 Feb 21.

54. Lai Q, Avolio AW, Manzia TM, Sorge R, Agnes S, Tisone G, Berloco PB, Rossi M. of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. Clin Transplant. 2011 Dec 22.

55. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, Manzia TM, Angelico R, Swinkels DW, Tjalsma H, López M, Abraldes JG, Bonaccorsi-Riani E, Jaeckel E, Taubert R, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest. 2012;122:368-82.

56. Anselmo A, Rossi P, De Mayo A, Manzia TM, Iaria G, Toti L, Tisone G. Assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. Minerva Chir. 2011;66:495-9.

57. Almerighi C, Bergamini A, Lionetti R, Sinistro A, Lenci I, Tariciotti L, Tisone G, Angelico M. Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients. Dig Liver Dis. 2012;44:67-73.

58. Lai Q, Avolio AW, Manzia TM, Agnes S, Tisone G, Berloco PB, Rossi M. Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? Int J Biol Markers. 2011;26:153-159.

59. Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant. 2011;11:2724-36.

60. Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, Anselmo A, Angelico M, Tisone G. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc. 2011;43:1181-3.

61. Iaria G, Sforza D, Angelico R, Toti L, de Luca L, Manuelli M, Bellini I, Manzia TM, Anselmo A, Tisone G. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. Transplant Proc. 2011;43:1028-9.

62. Manzia TM, Gravante G, Di Paolo D, Orlando G, Toti L, Bellini MI, Ciano P, Angelico M, Tisone G. Liver transplantation for the treatment of nodular regenerative hyperplasia. Dig Liver Dis. 2011;43:929-34.

63. Framarino dei Malatesta M, Corona LE, De Luca L, Rocca B, Manzia TM, Orlando G, Tisone G, Iaria G. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Transplantation. 2011;9:e69-71.

64. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Manzia TM, Bellini MI, Corona L, Toti L, Fratoni S, Cillis A, Orlando G, Tisone G. Transpl Int. 2011;24:e69-70.

65. Manzia TM, Angelico R, Toti L, Bellini MI, Sforza D, Palmieri G, Orlando G, Tariciotti L, Angelico M, Tisone G. Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C. Transpl Int. 2011 Feb 5. doi: 10.1111/j.1432-2277.2011.01228.x.

66. Lenci I, Tisone G, Di Paolo D, Marcuccilli F, Tariciotti L, Ciotti M, Svicher V, Perno CF, Angelico M. Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver Transplanted for HBV-Related Cirrhosis at Low Risk of HBV Recurrence. J Hepatol. 2011 Jan 17. [Epub ahead of print]

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 9 of 14

67. Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M,Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L,Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G,Rossi M, Zamboni F; Liver Match Investigators. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis. 2011 Feb;43(2):155-64. Epub 2010 Dec 24.

68. Manzia TM, Gravante G, Toti L, Iaria G, Anselmo A, Fratoni S, Angelico R, Sforza D, Manuelli M, Tisone G. Management of spermatic cord liposarcoma in renal transplant recipients: case report. Transplant Proc. 2010 May;42(4):1355-7.

69. Manuelli M, De Luca L, Iaria G, Tatangelo P, Sforza D, Perrone L, Bellini MI, Angelico R, Anselmo A, Tisone G. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Transplant Proc. 2010 May;42(4):1314-6.

70. Manzia TM, Toti L, Angelico R, Di Cocco P, Orlando G, Tisone G. Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. Transplant Proc. 2010 May;42(4):1237-9.

71. Manzia TM, Di Paolo D, Sforza D, Toti L, Angelico R, Brega A, Angelico M, Tisone G. Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results. Transplant Proc. 2010 May;42(4):1200-3.

72. Iaria G, Pisani F, De Luca L, Sforza D, Manuelli M, Perrone L, Bellini I, Angelico R, Tisone G. Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. Transplant Proc. 2010 May;42(4):1169-70.

73. Orlando G, Di Cocco P, D'Angelo M, Clemente K, Manzia TM, Angelico R, Tisone G, Romagnoli J, Citterio F, Famulari A, Pisani F. Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. Transplant Proc. 2010 May;42(4):1118-9.

74. Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G, Angelico M. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis. Transpl Int. 2010 Nov;23(11):1105-12. doi: 10.1111/j.1432-2277.2010.01104.x. Epub 2010 Aug 19.

75. Puig-Pey I, Bohne F, Benítez C, López M, Martínez-Llordella M, Oppenheimer F, Lozano JJ, González-Abraldes J, Tisone G, Rimola A, Sánchez-Fueyo A. Characterization of γδ T cell subsets in organ transplantation. Transpl Int. 2010 Oct;23(10):1045-55.

76. Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis. 2010 Aug;42(8):578-84. Epub 2010 Jan 22.

77. Salvadori M, Scolari MP, Bertoni E, Citterio F, Rigotti P, Cossu M, Dal Canton A, Tisone G, Albertazzi A, Pisani F, Gubbiotti G, Piredda G, Busnach G, Sparacino V, Goepel V, Messa P, Berloco P, Montanaro D, Veroux P, Federico S, Bartezaghi M, Corbetta G, Ponticelli C. Everolimus with very low-exposurecyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation. 2009 Nov 27;88(10):1194-202.

78. Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Dig Liver Dis. 2010 Apr;42(4):297-303. Epub 2009 Oct 8.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 10 of 14

79. Orlando G, Tariciotti L, Manzia TM, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke GM, Soker S, Baiocchi L, Lerut J, Angelico M, Tisone G. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. Transpl Infect Dis. 2010 Feb;12(1):11-5. Epub 2009 Sep 9.

80. Toti L, Manzia TM, Romano P, Lenci I, Baiocchi L, Anselmo A, Sforza D, Manuelli M, Tisone G. Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. Transpl Int. 2010 Jan;23(1):114-5. Epub 2009 Jul 10.

81. Gentileschi P, Venza M, Benavoli D, Lirosi F, Camperchioli I, D'Eletto M, Lazzaro A, Stolfi VM, Anselmo A, Di Lorenzo N, Tisone G, Gaspari AL. Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. Obes Surg. 2009 Oct;19(10):1460-3. Epub 2009 Jun 9.

82. de Liguori Carino N, Manzia TM, Tariciotti L, Berlanda M, Orlando G, Tisone G. Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. Transplant Proc. 2009 May;41(4):1386-9.

83. Pompili M, Pacella CM, Francica G, Angelico M, Tisone G, Craboledda P, Nicolardi E, Rapaccini GL, Gasbarrini G. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. Eur J Radiol. 2010 Jun;74(3):e6-e11. Epub 2009 Apr 3.

84. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43. Epub 2008 Dec 4.

85. Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl Immunol. 2008 Nov;20(1-2):43-7. Epub 2008 Sep 4.

86. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest. 2008 Aug;118(8):2845-57.

87. Lenci I, Angelico M, Tisone G, Orlacchio A, Palmieri G, Pinci M, Bombardieri R, Curatolo P. Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment. J Hepatol. 2008 Jun;48(6):1026-9. Epub 2008 Mar 31.

88. Baiocchi L, Tisone G, Russo MA, Longhi C, Palmieri G, Volpe A, Almerighi C, Telesca C, Carbone M, Toti L, De Leonardis F, Angelico M. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway. Transpl Int. 2008 Aug;21(8):792-800. Epub 2008 Apr 23.

89. Piazza A, Poggi E, Ozzella G, Borrelli L, Scornajenghi A, Iaria G, Tisone G, Adorno D. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry.Clin Transpl. 2006:323-36.

90. Lenci I, Tariciotti L, Baiocchi L, Manzia TM, Toti L, Craboledda P, Callea F,Angelico M, Tisone G. Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma. Transpl Int. 2008 Jun;21(6):598-601. Epub 2008 Mar 18.

91. Baiocchi L, Angelico M, Petrolati A, Perrone L, Palmieri G, Battista S, Carbone M, Tariciotti L, Longhi C, Orlando G, Tisone G. Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease. Am J Transplant. 2008 Mar;8(3):673-8.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 11 of 14

92. Orlando G, Sabbà C, De Liguori Carino N, Scelzo C, Tariciotti L, Bonanni L, D'Angelo M, Baiocchi L, Lerut J, Tisone G. Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report. Liver Int. 2008 Apr;28(4):574-7. Epub 2007 Sep 26.

93. Iaria G, Anselmo A, De Luca L, Manuelli M, Lucchesi C, Tariciotti L, Monaco A, Sforza D, Nigro F, Abruzzese E, Tisone G. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports. Transplant Proc. 2007 Jul-Aug;39(6):2036-7.

94. Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G. A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. J Hepatol. 2007 Jun;46(6):1009-17. Epub 2007 Feb 5.

95. Tisone G, Orlando G, Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol. 2007 Feb;17(2):108-13. Epub 2006 Sep 27.

96. Martínez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, Lerut J, Latinne D, Margarit C, Bilbao I, Brouard S, Hernández-Fuentes M, Soulillou JP, Sánchez-Fueyo A. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant. 2007 Feb;7(2):309-19.

97. Orlando G, Baiocchi L, Cardillo A, Iaria G, De Liguori Carino N, De Luca L, Ielpo B, Tariciotti L, Angelico M, Tisone G. Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension. Liver Transpl. 2007 Jan;13(1):46-54.Erratum in: Liver Transpl. 2007 May;13(5):778. De Liguori, Nicola [corrected to De Liguori Carino, Nicola].

98. Cescon M, Spada M, Colledan M, Torre G, Andorno E, Valente U, Rossi G, Reggiani P, Cillo U, Baccarani U, Grazi GL, Tisone G, Filipponi F, Rossi M, Ettorre GM, Salizzoni M, Cuomo O, De Feo T, Gridelli B. Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg. 2006 Nov;244(5):805-14.

99. Di Paolo D, Lenci I, Trinito MO, Carbone M, Longhi C, Tisone G, Angelico M. Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins. Dig Liver Dis. 2006 Oct;38(10):749-54. Epub 2006 Aug 17.

100. Iaria G, Iorio B, Anselmo A, De Luca L, Tariciotti L, Ielpo B, Muzi F, Lucchesi C, D'Andria D, Orlando G, Del Poeta G, Poggi E, Piazza A, Tisone G. Graft failure due to hemolytic uremic syndrome recurrence. Transplant Proc. 2006 May;38(4):1020-1.

101. Iaria G, Pisani F, Iorio B, Lucchesi C, De Luca L, Ielpo B, D'Andria D, Tariciotti L, Tisone G. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression. Transplant Proc. 2006 May;38(4):1018-9.

102. Piazza A, Poggi E, Ozzella G, Borrelli L, Monaco PI, Scornajenghi A, Tisone G, Adorno D. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. Transplantation. 2006 May 15;81(9):1298-305.

103. Baiocchi L, Angelico M, De Luca L, Ombres D, Anselmo A, Telesca C, Orlando G, D'Andria D, Tisone G. Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transpl Int. 2006 May;19(5):389-95.

104. Baiocchi L, Tisone G, Falasca L, Telesca C, Di Paolo D, Orlando G, Furfaro S, Anselmo A, Carbone M, Angelico M. Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: A biochemical and ultra-structural study in humans. Hepatol Res. 2006 Jul;35(3):215-21. Epub 2006 Apr 19.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 12 of 14

105. Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006 Apr;44(4):702-9. Epub 2006 Jan 4.

106. Orlando G, Cardillo A, Anselmo A, De Luca L, Toti L, Muzi F, Ielpo B, Angelico M, Tisone G. Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. Transplant Proc. 2005 Jul-Aug;37(6):2629-31.

107. Manzia TM, De Liguori Carino N, Orlando G, Toti L, De Luca L, D'Andria D, Cardillo A, Anselmo A, Casciani CU, Tisone G. Use of mycophenolate mofetil in liver transplantation: a literature review. Transplant Proc. 2005 Jul-Aug;37(6):2616-7. Review.

108. Splendiani G, Cipriani S, Tisone G, Iorio B, Condo S, Vega A, Dominijanni S, Casciani CU. Infectious complications in renal transplant recipients. Transplant Proc. 2005 Jul-Aug;37(6):2497-9.

109. Di Paolo D, Lenci I, Trinito MO, Tisone G, Angelico M. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. Dig Liver Dis. 2005 Oct;37(10):793-8.

110. Gandini R, Konda D, Tisone G, Pipitone V, Anselmo A, Simonetti G. Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. Cardiovasc Intervent Radiol. 2005 Nov-Dec;28(6):828-31.

111. Muzi F, Orlando G, Ielpo B, Anselmo A, Sabato Ceraldi S, de Liguori Carino N, Manzia T, D'Andria D, Tariciotti L, Angelico M, Tisone G. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. Transplant Proc. 2005 May;37(4):1705-7. Erratum in:Transplant Proc. 2007 Jul-Aug;39(6):2048. de'Liguori Carino, N [corrected to de Liguori Carino, N].

112. Cescon M, Spada M, Colledan M, Andorno E, Valente U, Rossi G, Reggiani P, Grazi GL, Tisone G, Majno P, Rogiers X, Santamaria ML, Baccarani U, Ettorre GM, Cillo U, Rossi M, Scalamogna M, Gridelli B. Split-liver transplantation with pediatric donors: a multicenter experience. Transplantation. 2005 May 15;79(9):1148-53.

113. Genovese D, Dettori S, Argentini C, Kondili LA, La Sorsa V, Tisone G,Angelico M, Rapicetta M. Molecular characterisation of SENV and TTV infections in hepatopathic liver-transplant patients. Brief Report. Arch Virol. 2004 Jul;149(7):1423-33. Epub 2004 Apr 5.

114. Di Paolo D, Tisone G, Piccolo P, Lenci I, Zazza S, Angelico M. Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. Transplantation. 2004 Apr 27;77(8):1203-8.

115. Tisone G, Manzia TM, Zazza S, De Liguori Carino N, Ciceroni C, De Luca I, Toti L, Casciani CU. Marginal donors in liver transplantation. Transplant Proc. 2004 Apr;36(3):525-6.

116. Orlando G, De Luca L, Toti L, Zazza S, Angelico M, Casciani CU, Tisone G. Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplant Proc. 2004 Jan-Feb;36(1):199-202.

117. Petrolati A, Festi D, De Berardinis G, Colaiocco-Ferrante L, Di Paolo D, Tisone G, Angelico M. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment PharmacolTher. 2003 Oct 15;18(8):785-90.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 13 of 14

118. Lupattelli T, Garaci FG, Sandhu C, Tisone G, Simonetti G. Endovascular treatment of giant splenic aneurysm that developed after liver transplantation. Transpl Int. 2003 Oct;16(10):756-60. Epub 2003 Jun 28.

119. Angelico F, Del Ben M, Francioso S, Hurtova M, Battista S, Palmieri GP, Tisone G, Angelico M. Recurrence of insulin resistant metabolic syndrome following liver transplantation. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):99-102.

120. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Di Nicuolo G, Amoroso P, Spadari A, Lombardi G, Hoekstra R,Calise F, Chamuleau RA. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs. 2002 Oct;25(10):950-9.

121. Bergamini A, Cepparulo M, Bolacchi F, Araco A, Tisone G, Ombres D, Rocchi G, Angelico M. Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. Clin Exp Immunol. 2002 Nov;130(2):293-9.

122. Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B, Rezza G. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect. 2001 Oct;43(3):195-9.

123. Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, Casciani CU, Tisone G. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology. 2002 Jan;35(1):176-81.

124. Falasca L, Tisone G, Palmieri G, Anselmo A, Di Paolo D, Baiocchi L, Torri E, Orlando G, Casciani CU, Angelico M. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation. 2001 May 5;71(9):1268-76.

125. L F, G T, G P, A A, D DP, L B, E T, G O, CU And C, M A. Protective role tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation 2001; 71: 1268. Transplantation. 2001 May 15;71(9):1205-1206.

126. Salizzoni M, Cavallari A, Risaliti A, Filipponi F, Gerunda GE, Forti D, Fassati LR, Cillo U, Castagneto M, Valente U, Tisone G. Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. Transplant Proc. 2001 May;33(3):2258-62.

127. Pisani F, Buonomo O, Iaria G, Tisone G, Mazzarella V, Pollicita S, Camplone C, Piazza A, Valeri M, Famulari A, Casciani CU. Preliminary results of a prospective randomized study of basiliximab in kidney transplantation. Transplant Proc. 2001 Feb-Mar;33(1-2):2032-3.

128. Iaria G, Tisone G, Pisani F, Buonomo O, Camplone C, Pollicita S, Torri E, Anselmo A, Casciani CU. High-pressure perfusion versus gravity perfusion in liver harvesting: results from a prospective randomized study. Transplant Proc. 2001 Feb-Mar;33(1-2):957-8.

129. Falasca L, Tisone G, Orlando G, Baiocchi L, Vennerecci G, Anselmo A, Torri E, Di Paolo D, Strati F, Casciani CU, Angelico M. Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study. Transplant Proc. 2000 Feb;32(1):49-50.

130. Tisone G, Orlando G, Pisani F, Iaria G, Negrini S, Pollicita S, Strati F, Nanni G, Castagneto M, Casciani CU. Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. Transplant Proc. 1999 Dec;31(8):3386-7.

131. Cervelli V, Orlando G, Giudiceandrea F, Grimaldi M, Pisani F, Strati F, Iaria G, Piccione E, Torri E, Carluccio C, Tisone G, Casciani CU. Gigantomastia and breast lumps in a kidney transplant recipient. Transplant Proc. 1999 Dec;31(8):3224-5.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 14 of 14

132. Tisone G, Laria G, Orlando G, Pisani F, Palmieri GP, Bellanova G, Torri E, Buonomo O, Angelico M, Casciani CU. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation. Transplant Proc. 1999 Dec;31(8):3167-8.

133. Tisone G, Orlando G, Vennarecci G, Palmieri GP, Pisani F, Strati E, Anselmo A, Angelico M, Casciani CU. Spontaneous resolution of severe acute rejection in liver transplantation. Transplant Proc. 1999 Dec;31(8):3164-6.

134. Tisone G, Mercadante E, Dauri M, Colella D, Anselmo A, Romagnoli J, Vennarecci G, Casciari CU. Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study.Transplant Proc. 1999 Dec;31(8):3162-3.

135. Tisone G, Angelico M, Orlando G, Palmieri GP, Strati F, Di Paolo D, Casciani CU. Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids. Transplant Proc. 1999 Nov;31(7):2908-9.

136. Angelico M, Tisone G, Baiocchi L, Palmieri G, Pisani F, Negrini S, Anselmo A, Vennarecci G, Casciani CU. One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):462-8.

137. Merli M, Leonetti F, Riggio O, Valeriano V, Ribaudo MC, Strati F, Tisone G, Casciani CU, Capocaccia L. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology. 1999 Sep;30(3):649-54. Erratum in: Hepatology 2000 Aug;32(2):446. Sprati F [corrected to Strati F].

138. Tisone G, Angelico M, Palmieri G, Pisani F, Anselmo A, Baiocchi L, Negrini S, Orlando G, Vennarecci G, Casciani CU. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation. 1999 May 27;67(10):1308-13.

139. Tisone G, Baiocchi L, Orlando G, Palmieri GP, Pisani F, Rapicetta M, Strati F, Anselmo A, Torri E, Bellanova G, Casciani CU, Angelico M. Hepatitis C reinfection after liver transplantation in relation to virus genotype. Transplant Proc. 1999 Feb-Mar;31(1-2):490-1.

140. Iani C, Tisone G, Loberti M, Orlando G, Negrini S, Strati F, Bernardi G, Casciani CU. Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. Transplant Proc. 1999 Feb-Mar;31(1-2):404-5.

141. Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, Casciani CU, Angelico M. Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg. 1998 Nov;4(6):441-7.

142. Tisone G, Angelico M, Vennarecci G, Palmieri G, Orlando G, Iaria G, Baiocchi L, Casciani CU. Liver transplantation for end-stage liver disease related to viral hepatitis. Transplant Proc. 1998 Aug;30(5):1843-5.

143. Tisone G, Orlando G, Mercadante E, Vennarecci G, Pisani F, Buonomo O, Negrini S, Casciani CU. Neoral versus Sandimmune in kidney transplantation. Transplant Proc. 1998 Aug;30(5):1749-50.

144. Vennarecci G, Pisani F, Tisone G, Buonomo O, Famulari A, Casciani CU. Advantages of Neoral conversion in renal transplant patients. Minerva Urol Nefrol. 1998 Jun;50(2):161-4.

145. Tisone G, Angelico M, Palmieri G, Pisani F, Baiocchi L, Vennarecci G, Anselmo A, Orlando G, Negrini S, Casciani CU. Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study. Transpl Int. 1998;11 Suppl 1:S267-9.

146. Tisone G, Angelico M, Vennarecci G, Palmieri G, Buonomo O, Negrini S, Casciani CU. Metabolic findings after liver transplantation within a randomised trial with or without steroids. Transplant Proc. 1998 Jun;30(4):1447-8.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 15 of 14

147. Tisone G, Vennarecci G, Pisani F, Baiocchi L, Mercadante E, Orlando G, Anselmo A, Casciani CU. Reduced acute rejection and side effects with neoral in liver transplantation. Transplant Proc. 1998 Jun;30(4):1430-1.

148. Porzio S, Lombardi V, Buonomo O, Cervelli V, Chiusano R, Tisone G, Pisani F. [Diverticulosis of the gallbladder. A case report and review of the literature]. Minerva Chir. 1998 Mar;53(3):213-8. Italian.

149. Tisone G, Baiocchi L, Orlando G, Gandin C, Romagnoli J, Cepparulo M, Pisani F, Angelico M, Casciani CU. Liver transplantation for hepatitis C virus end-stage liver cirrhosis as compared with other nonviral indications. Transplant Proc. 1998 May;30(3):696-7.

150. Angelico M, Tisone G, Rapicetta M, Pisani F, Gandin C, Chionne P, Dettori S, Iaria G, Danese V, Orlando G, Casciani CU. Hepatitis C virus infection in Italian kidney graft recipients. Changing risk factors and hepatitis C virus genotypes. Ital J Gastroenterol Hepatol. 1997 Oct;29(5):448-55.

151. Tisone G, Vennarecci G, Baiocchi L, Negrini S, Palmieri GP, Angelico M, Dauri M, Casciani CU. Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion. Transplant Proc. 1997 Dec;29(8):3460-2.

152. Piazza A, Adorno D, Torlone N, Valeri M, Poggi E, Monaco PI, Pisani F, Tisone G, Casciani CU. Flow cytometric analysis of antidonor-specific antibodies in liver transplant. Transplant Proc. 1997 Nov;29(7):2975-6.

153. Tisone G, Romagnoli J, Vennarecci G, Anselmo A, Angelico M, Gandin C, Dauri M, Casciani CU. Is donor age a risk factor for poor graft function after orthotopic liver transplantation? Transplant Proc. 1997 Nov;29(7):2825-6.

154. Pisani F, Vennarecci G, Tisone G, Buonomo O, Iaria G, Rossi S, Famulari A, Casciani CU. Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. Transplant Proc. 1997 Nov;29(7):2812-3.

155. Vennarecci G, Pisani F, Tisone G, Buonomo O, Romagnoli J, Pasqua C, Famulari A, Casciani CU. Kidney transplantation and pregnancy. Transplant Proc. 1997 Nov;29(7):2797-8.

156. Mazzarella V, Splendiani G, Tozzo C, Tisone G, Pisani F, Iaria G, Casciani CU. Renal transplantation in patients with hereditary kidney disease: our experience. Contrib Nephrol. 1997;122:203-6.

157. Romagnoli J, Baiocchi L, Tisone G, Angelico M, Pisani F, Negrini S, Iaria G, Nistri A, Casciani CU. Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients. TransplantProc. 1996 Dec;28(6):3129-30.

158. Tisone G, Angelico M, Baiocchi L, Nistri A, Pisani F, Gandin C, Romagnoli J, Anselmo A, Umberto Casciani C. Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. Transplant Proc. 1996 Jun;28(3):1655-6.

159. Baiocchi L, Tisone G, Nistri A, Pisani F, Anselmo A, Gandin C, Angelico M, Casciani C. Sequential changes in serum and biliary bile acids after liver transplantation. Transplant Proc. 1995 Dec;27(6):3503-4.

160. Vennarecci G, Tisone G, Pisani F, Fiore A, Alciati E, Iorio B, Casciani CU.[Ureteral obstruction in the kidney transplant patient]. Minerva Urol Nefrol. 1995 Jun;47(2):59-64. Review. Italian.

161. Splendiani G, Mazzarella V, Tozzo C, Manni M, Pisani F, Tisone G, Feo M, Casciani CU. Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? Contrib Nephrol. 1995;115:150-3.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 16 of 14

162. Squillaci E, Crecco M, Apruzzese A, Capuozzo L, Mattioli M, Danese V, Tisone G, Cortese F, Simonetti G. [Magnetic resonance angiography in liver transplant patients. Follow-up of vascular anastomoses]. Radiol Med. 1995Jan-Feb;89(1-2):65-71. Italian.

163. Tisone G, Vennarecci G, Pisani F, Pieragostini E, Alciati E, Casciani CU. Cyclosporine A monitoring in liver transplant. Transplant Proc. 1994 Oct;26(5):2691-2.

164. Pisani F, Tisone G, Alciati E, Vennarecci G, Pieragostini E, Casciani CU.Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft. Transplant Proc. 1994 Oct;26(5):2602-3.

165. Elli M, Orlacchio A, Pisani F, Tisone G, De Paolis P, Utzeri G, Alciati E, Vennarecci G, Pieragostini E, Simonetti G, et al. Renal artery thrombosis in a pediatric renal transplant. Transplant Proc. 1994 Feb;26(1):77-8.

166. Tisone G, Pisani F, Utzeri G, Vennarecci G, Alciati E, Pieragostini E, Casciani CU. Preliminary reports from the New Liver Transplant Program at the University of Rome "Tor Vergata". Transplant Proc. 1993 Dec;25(6):3286-7.

167. Piazza A, Torlone N, Valeri M, Poggi E, Monaco PI, Provenzani L, Tisone G, Adorno D, Casciani CU. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant. Transplant Proc. 1993 Dec;25(6):3279-80.

168. Torlone N, Piazza A, Valeri M, Tisone G, Poggi E, Provenzani L, Monaco PI, Adorno D, Casciani CU. Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies. Transplant Proc. 1993 Dec;25(6):3275-6.

169. Deakin M, Gunson BK, Dunn JA, McMaster P, Tisone G, Warwick J, Buckels JA. Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Engl. 1993 Sep;75(5):339-44.

170. Valeri M, Pisani F, De Paolis P, Piazza A, Torlone N, Utzeri G, Elli M, Tisone G, Adorno D, Casciani CU. Hepatitis C virus infection in kidney transplant recipients. Transplant Proc. 1993 Jun;25(3):2284-5.

171. Elli M, Valeri M, Pisani F, Tisone G, Utzeri G, De Paolis P, Manca di Villahermosa S, Adorno D, Famulari A, Casciani CU. Developing countries as the major future source of living donor renal transplants. Transplant Proc. 1992 Oct;24(5):2110-1.

172. Valeri M, Elli M, Pisani F, Tisone G, De Paolis P, Utzeri G, Alciati E, Adorno D, Famulari A, Casciani CU. Unrelated living donor kidney transplant and developing countries. Transplant Proc. 1992 Oct;24(5):1896-7.

173. Famulari A, De Paolis P, Utzeri G, Valeri M, Elli M, Pisani F, Tisone G, Adorno D, Lombardo A, Casciani CU. Transplant organization in Italy. Transplant Proc. 1992 Oct;24(5):1855-6.

174. Elli M, Baroni B, Boffo B, Tisone G, Pisani F, Valeri M, Utzeri G, De Paolis P, Manca di Villahermosa S, Famulari A, et al. Renal transplant odyssey. Transplant Proc. 1992 Oct;24(5):1853-4.

175. Elli M, Baroni B, Boffo V, Famulari A, Tisone G, Pisani F, Utzeri G, De Paolis P, Di Villahermosa SM, Casciani CU. [Bladder diverticulosis appearing after kidney transplantation]. Minerva Chir. 1992 Apr 30;47(8):785-7. Italian.

176. Elli M, Baroni B, Boffo V, Famulari A, Tisone G, Pisani F, Utzeri G, De Paolis P, Di Villahermosa SM, Casciani CU. [An unusual case of ureteral obstruction after kidney transplantation]. Minerva Chir. 1992 Apr 30;47(8):781-3. Italian.

177. Badger IL, Czerniak A, Beath S, Tisone G, Deakin M, Sherlock DJ, Kelly DA, McMaster P, Buckels JA. Hepatic transplantation in children using reduced size allografts. Br J Surg. 1992 Jan;79(1):47-9.

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 17 of 14

178. Tisone G, Elli M, Pisani F, Utzeri G, De Paolis P, Torlone N, Manca da Villahermosa S, Famulari A, Casciani CU. Use of UW solution versus Euro-Collins solution in kidney transplantation from cadaveric donors. Transplant Proc. 1991 Oct;23(5):2402-3.

179. Buckels JA, Tisone G, Gunson BK, McMaster P. Low haematocrit reduces hepatic artery thrombosis after liver transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2460-1.

180. Casciani CU, Tisone G, Baroni B, Elli M, Pisani F. Long-term follow-up of renal transplants. Transplant Proc. 1989 Feb;21(1 Pt 2):2174-5.

181. Casciani CU, Baroni B, Boffo V, Elli M, Pisani F, Tisone G. Unusual case of bladder diverticula formation following renal transplant. Clin Transpl. 1989:298.

182. Tisone G, Gunson BK, Buckels JA, McMaster P. Raised hematocrit—a contributing factor to hepatic artery thrombosis following liver transplantation. Transplantation. 1988 Jul;46(1):162-3.

183. Buckels JA, Buist L, Aertz R, Tisone G, Quintero G, Michell I, McMaster P. Liver transplantation: the first 200 grafts in Birmingham. Clin Transpl. 1988:39-43.

184. Caruso U, Lezoche E, Mariani P, Elli M, Tisone G, Cravotto E, Casciani CU. Plasma levels of beta-endorphin in uraemic patients during haemodialysis. Int JClin Pharmacol Res. 1988;8(1):17-20.

185. Caruso U, Elli M, Cravotto E, Tisone G, Lombardo PA, Silvaroli M, Ficorella C, Cortesi E, Casciani CU. Colorectal cancer (Duke's group B2, C1, C2): adjuvant chemotherapy and toxicity. Mt Sinai J Med. 1985 Jun;52(6):470-2.

186. Caruso U, Tisone G, Lombardo PA, Cravotto E, Tavolaro M, Silvaroli M, Lucchetti G, Casciani CU. Gastrin release after endoluminal perfusion with cisapride of the isolated antrum in the pig. Boll Chim Farm. 1985 Mar;124(3):146-9.

187. Caruso U, Lezoche E, Elli M, Tisone G, Mariani P, D'Alessandro D, Cravotto E, Lombardo PA, Tavolaro M, Silvaroli M, et al. Digestive tract endoluminal perfusion of cisapride (R 51619) and effects on gastrointestinal hormone levels in anaesthetized pigs. Drugs Exp Clin Res. 1985;11(10):679-82.

188. Caruso U, Tisone G, Lombardo PA, Silvaroli M, Deodati M, Agostinelli G, Casciani CU. [A new technic for experimental measurement of biliary pressure].Boll Chim Farm. 1984 Jan;123(1):36-40. Italian.

189. Caruso U, Tisone G, Cravotto E, Casciani CU, D'Iddio S. Evaluation of liver regeneration after exeresis by determination of plasma carnitine levels in rats. Int J Tissue React. 1983;5(2):201-3.

190. Caruso U, Lezoche E, Ruscitto G, Elli M, Stortoni F, Tisone G, Carlei F, Casciani CU. Distribution of G-cells in the gastrointestinal mucosa of the uremic patient. Mt Sinai J Med. 1983 Jan-Feb;50(1):85-6.

191. Caruso U, Tisone G, Stortoni F, Cravotto E, Ecari U, Lucchetti G, Casciani CU. Evaluation of a peripheral dopaminergic blocking agent on the pancreatic secretion. Boll Chim Farm. 1982 Oct;121(10):525-9.

Membership Association “Società Italiana Trapianti d’Organo” “Europena Society Transplantation” “European Liver Transplant Association” “International Liver Transplantation Society”

Giuseppe Tisone CURRICULUM VITAE

CV 2016 Page 18 of 14

I conducted clinical research according to CGP and I authorize the use of my personal data according to D.Lgs. n° 196/2003. Signature: Date:

10th October 2016

Printed Name: Giuseppe Tisone